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Abstract
Hearing loss or ototoxicity is one of the major side effects associated with the use of the antibiotics, particularly
aminoglycosides (AGs), which are the most commonly used antibiotics worldwide. However, the molecular and cellular
events involved in the antibiotic-induced ototoxicity remains unclear. In the present study, we test the possibility that
prestin, the motor protein specifically expressed in the basolateral membrane of outer hair cells (OHCs) in the cochlea with
electromotility responsible for sound amplification, may be involved in the process of AG-induced apoptosis in OHCs. Our
results from both mice model and cultured cell line indicate a previously unexpected role of prestin, in mediating antibiotic-
induced apoptosis, the effect of which is associated with its anion-transporting capacity. The observed downregulation of
prestin mRNA prior to detectable apoptosis in OHCs and hearing loss in the antibiotic-treated mice is interesting, which may
serve as a protective mechanism against hearing loss induced by AGs in the early stage.
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Introduction
Despite their well known side effects such as ototoxicity and
nephrotoxicity, aminoglycosides (AGs) are still the most commonly
used antibiotics world- wide due to their high efficacy and low cost.
However, their extensive usage in developing countries recent
years have resulted in significantly higher incidences of drug
toxicity, which could be a result of increased application in
multidrug-resistant tuberculosis requiring long-term therapy, over
the counter availability and poor monitoring of auditory function
following over-course treatment [1]. The incidence of AGs-
associated hearing loss reported ranges from a few percent up to
33% and is projected to afflict more people worldwide in the next
twenty years due to the outbreak of drug-resistant tuberculosis in
developing countries [2].
All AGs have the potential to induce severe and irreversible
ototoxicity; however, the mechanisms underlying AGs-induced
hearing loss or ototoxicity remain unclear. Prolonged exposure of
the cochlear cells to AGs is apparently linked to the damage of the
outer hair cells (OHCs) in the organ of Corti, leading to permanent
hair cell loss and hearing damage [3,4]. Many studies have indicated
that generation of free radicals, abnormal iron transport, dysfunction
of mitochondria, gene mutations and drug-drug interactions are
involved in ototoxicity induced by AGs [5,6,7,8,9,10]. These cellular
events can initiate several different mechanisms of cell death
depending on the type of AGs exposure. While necrotic death has
been observed in animal models for decades, numerous studies have
also shown that AGs-induced apoptosis in OHC is responsible for the
drug-induced hearing damage [3,11,12,13].
OHCs in the mammalian cochlea, apart from being the sensory
unit, also generate force to amplify sound-induced displacements
of the basilar membrane thus enhancing auditory sensitivity and
frequency selectivity. This force generation is attributed to the
voltage-dependent contractility of the OHCs underpinned by the
motor protein, prestin. Prestin, a member of the SLC26 anion
transporter family, is located at the basolateral wall of OHCs and
responsible for their voltage-driven electromotility[14]. Early
studies failed to demonstrate ion transporting capacity of prestin,
unlike its nonmammalian orthologs and mammalian family
members. It has been suggested that the prestin’s voltage-sensing
capacity requires an incomplete transport cycle which depends on
its binding and hemimovement of anions within the intramem-
branous protein [15,16]. However, a recent study demonstrated
that prestin was able to transport anions, such as chloride or
bicarbonate, across the membrane, which could act as voltage
sensor localized at the cytoplasmic side of the membrane [17].
Given that OHCs, which specifically express prestin, are prone to
undergo apoptosis in response to AGs, it is tempting for us to
speculate and test the possibility that prestin may be involved in
the process of AGs-induced apoptosis in OHCs.
Results
Chronic kanamycin treatment leads to hearing and OHC
damage
Mice were subcutaneously injected with kanamycin (750 mg/
kg, twice daily) for different periods of time and hearing loss was
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(ABR). As shown in Figure 1, saline-injected mice maintained
stable hearing response at any frequency tested during treatment.
There were no significant changes in ABR thresholds after 7 days
of kanamycin treatment; however, continued injection of kana-
mycin for 14 days resulted in a frequency-dependent threshold
shift. In addition, consecutive injection for 21 days led to
significant threshold shifts at all frequencies tested, with the largest
threshold shift of about 35–40 dB peaked at 20 kHz (Fig. 1).
It has been previously shown that ototoxicity induced by AGs is
a result of irreversible damage in OHC [18]. To correlate the
time-dependent changes in auditory threshold shift with structural
changes induced by kanamycin in OHCs, we examined structural
integrity on cochlear sections from animals treated with kanamy-
cin at the same time points as that for ABR experiments. In saline-
treated mice, FITC-phalloidin staining for F-actin showed the
well-defined outline of OHCs (Fig. 2Aa). After treatment with
kanamycin for 7 days, there was no apparent loss of OHC
(Fig. 2Ab), whereas continued injections resulted in some initial
death of OHC after 14 days (Fig. 2Ac). 21 days after kanamycin
administration, normal structure of basilar membrane collapsed,
almost all OHCs disappeared, and the space at which OHCs were
located was filled with scarred structure (Fig. 2Ad). These results
are consistent with the time-dependent functional deficits
determined by the ABR measurements.
Kanamycin induces apoptosis and downregulates prestin
expression in OHC
Apoptosis-related mechanisms have been proposed to be the
pathophysiological basis of AGs-induced ototoxicity [4,19]. To
examine the effect of kanamycin on apoptosis in the cochleae, we
stained the cochlear sections with TUNEL. In agreement with the
functional and morphological result, we did not observe any dying
cells in saline controls or after 7 days of kanamycin-treatment
(Fig. 2Ba&b). After 14 days of drug treatment, some TUNEL
reactive cells were observed in OHCs (Fig. 2Bc). In contrast, 21
days of consecutive treatment produced substantial amount of
TUNEL-positive cells in OHCs (Fig. 2Bd). Of note, after 21 days
of kanamycin treatment, besides OHCs, apoptotic signals were
also observed in stria vascularis, supporting cells and spiral
ganglion cells as well (data not shown). Taken together, the
administration of kanamycin causes time-dependent hearing loss
and pronounced damage of OHCs. This chronic detrimental
effect is mainly attributed to kanamycin-induced apoptosis in
OHCs.
The answer to the question why OHCs are more susceptible to
drug-induced apoptosis compared to Inner Hair Cells (IHCs)
remains elusive. Given the specific expression of prestin in OHCs,
we speculated that prestin might be involved in the modulation of
kanamycin-induced apoptosis in OHCs and thus examined its
expression during the course of kanamycin treatment. As shown
by immunostaining in Fig. 2C, prestin-positive staining in the cross
section of OHCs was well organized with three rows of prestin-
positive cells in the basilar membrane in control (Fig. 2Ca);
however, prestin immuoreactive signal was lost in the severely
destroyed OHCs after 21 days of treatment (Fig. 2Cd). Further
studies on paraffin sections of the cochlea showed that in the
control organ of corti, prestin was localized at the basolateral
plasma membrane of three OHCs in an orderly manner (Fig. 2Da).
However, kanamycin administration markedly altered the expres-
sion of prestin in a time-dependent manner. At day 21, prestin
immunoreactivity was severely deranged (Fig. 2Dd).
We also analyzed time-dependent prestin mRNA expression in
the organ of corti with or without kanamycin treatment by Q-
PCR. As shown in Figure 2E, a time-dependent reduction in
prestin mRNA levels was observed in response to kanamycin
treatment compared to the untreated control. Of particular
importance, we noted a significant reduction in prestin mRNA
level 7 days after drug administration which preceded the
observed structural damage of OHCs (Fig. 2A), indicating that
the kanamycin-induced down-regulation of prestin expression was
not secondary to OHC loss, at least not before day 14. The finding
that kanamycin suppresses the expression of prestin, which is vital
for hearing amplification in mammals, prior to its damaging action
on OHCs may explain the clinical observation that the AGs-
induced ototoxicity commonly starts with hearing threshold shift
and followed by irreversible hearing loss in patients with chronic
aminoglycoside treatment.
Overexpression of prestin in Chinese Hamster Ovary
(CHO) cells enhances kanamycin-induced apoptosis
Does prestin play a role in the kanamycin-induced apoptosis? If
yes, through what mechanism? To answer these questions and
taking into the consideration that very limited number of OHCs
could be isolated from the cochlea, we transfected CHO cells,
which do not express endogenous prestin, with prestin and
compared their response to kanamycin to that in CHO cells
transfected with empty vector. After transfection, over 90% of
CHO cells expressed prestin, which was localized predominantly
at the plasma membrane (Fig. 3A). MTS assay results showed that
treatment with 100 mM Kanamycin for 2 h significantly decreased
number of viable cells in prestin-expressing CHO cells compared
with the vector control (Fig. 3B). Further TUNEL assay showed
that while kanamycin did not induce significant apoptosis in
control-vector transfected CHO cells, the forced expression of
prestin significantly increased the number of apoptotic cells in
kanamycin-treated CHO cells (Fig. 3C), indicating a predominant
role of prestin in the kanamycin-induced apoptosis.
Prestin-expressing CHO cells exhibit anion transporting
capacity
Having established that prestin-expressing cells are more
susceptible to kanamycin-induced apoptosis, we next sought to
investigate possible mechanisms underlying this differential
Figure 1: Threshold shifts in mice treated with kanamycin.
BALB/c male mice, 4 weeks old, 10 each group, were administrated with
kanamycin at 750 mg/kg with subcutaneous injection twice daily.
Saline injection was served as a control. Thresholds of ABR were
measured with tone-pip pure tone at 4 k, 8 k, 12 k, 16 k, 20 k, 24 k, and
32 k Hz. Thresholds of hearing shifted upward in a time-dependent
manner after 14 days of treatment.
doi:10.1371/journal.pone.0017322.g001
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voltage-sensing and ion transporting capacities [20,21], it may
sense membrane voltage changes induced by kanamycin, a known
ionophore allowing influx of cations [22], with conformational
changes that facilitate anion transporting capacity of prestin. We
first examined whether kanamycin could induce membrane
potential changes in prestin-transfected or vector control CHO
cells. As shown in Figure 4A, 100 mM kanamycin induced a rapid
depolarization of membrane potential as reflected by a sharp rise
in the fluorescence intensity of the voltage-sensitive dye
(DiBAC4(3)) in both vector control and prestin-expressing CHO
cells (Fig. 4Aa,b), indicating cation influx induced by kanamycin as
expected. Interestingly, the change in membrane potential in the
prestin-expressing CHO cells was less than that of the vector
control (Fig. 4Ad). In addition, the initial rate of increase in
membrane potential in the prestin-expressing CHO cells also
Figure 2: Kanamycin induces hearing damage, apoptosis and down-regulation of prestin in OHC. 4 week old BALB/c male mice were
injected with 750 mg/kg kanamycin subcutaneously twice daily for the time indicated. (A): FITC-conjugated phalloidin (green) staining on cross
section of OHC. a, normal control; b, ka-7d; c, ka-14d; d, ka-21d. Scale bar=20 mm. (B): TUNEL assay of cochlear sections. Cochlear sections were
stained with TUNEL (green) and propidium iodide (red). a, Normal morphology and no TUNEL-positive staining was found in inner ear cells in saline-
treated control animals; b–d, 7, 14 and 21 days of kanamycin treatment. The sections shown are representative of three individual animals at each
time point. Scale bar=25 mm. Green arrow head: OHC cells. (C): Rhodamine-conjugated prestin staining on cross section of OHC. a, Normal, normal
staining of prestin with three rows of rings; b, ka-7d; c, ka-14d; d, ka-21d. Scale bar=15 mm. (D): Prestin immunofluorescence staining of cochlear
sections. Cochlear sections of control, 7, 14 and 21 days after kanamycin treatment were stained with prestin at 1:100 dilutions. Scale bar=50 mm.
Left column: immunostaining merged with bright field image; Middle column: PI (red) merged with Prestin (green); white rectangle indicated
enlarged area shown in right column. Three OHC cells. (E): Q-RT-PCR analysis of prestin expression in kanamycin- treated mouse cochlea. Q-RT- PCR
was performed using validated Taqman
TM Gene Expression Assays as described in Materials and Methods. Kanamycin significantly down-regulated
prestin expression. *, p,0.05; ***, p,0.01.
doi:10.1371/journal.pone.0017322.g002
Prestin Mediated Apoptosis in Ototoxicity
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e17322appeared to be slower as compared to that of vector control,
although there was no significant difference (Fig. 4Ac). These
results suggest possible concurrent influx of anions through prestin
or other channels, which counteracts with the part of effect of the
kanamycin-induced cation influx on membrane potential.
Next, we set out to determine whether the prestin-expressing
CHOs indeed possess the anion-transporting capacity. Using a
fluorescent indicator MAQE for intracellular chloride, we
compared changes in intracellular chloride concentrations in
response to kanamycin challenge in vector control and prestin-
expressing CHO cells. As shown in Figure 4B, kanamycin
treatment (100 mM) resulted in a significant increase in intracel-
lular chloride concentration in prestin-expressing cells compared
to that in control cells, indicating that prestin is required for
mediating the kanamycin-induced change in intracellular chloride
concentrations. When chloride was removed from the extracellular
solution, the kanamycin-induced change in intracellular chloride
was abolished (Fig. 4C), indicating that the kanamycin-induced
change was due to chloride influx, which might be mediated by
prestin with its anion-transporting capability.
Prestin-enhanced kanamycin-induced apoptosis
depends on extracellular chloride
Since anion fluxes have been implicated in regulating apoptotic
activities in different cell types [23,24], the requirement of prestin
in mediating the kanamycin-induced chloride influx suggests that
the anion-transporting property induced by prestin is likely to
contribute to the kanamycin-induced apoptosis. In other words,
the kanamycin-induced apoptosis should depend on both prestin
and extracellular chloride. To test this, we treated either the
control or prestin-transfected CHO cells with kanamycin in the
presence or absence of extracellular chloride in Krebs-Henseleit
(KH) solution, the ion composition of which could be manually
manipulated. As shown in Fig. 5, forced expression of prestin
significantly potentiated kanamycin-induced apoptosis as detected
by TUNEL assay compared with the prestin-lacking control when
cells were incubated in the chloride-containing KH solution,
which was similar to that when cells were incubated in chloride-
containing culture media (Fig. 5A). When cells were incubated in
chloride-free KH solution, the kanamycin-induced effect in
prestin-expressing CHO cells was abolished, indicating that the
kanamycin-induced apoptosis depended on extracellular chloride.
Thus, it appears that the anion-transporting capacity induced by
prestin is involved in mediating the enhancement effect of prestin
on the kanamycin-induced apoptosis.
Changes of chloride conductance have been suggested to
correlate closely with the onset of apoptosis, through interaction
with Bcl-2 family of proteins, both in vitro and in vivo [25,26]. To
explore the molecular mechanism underlying prestin-mediated
apoptosis, both control and prestin-transfected CHO cells treated
with kanamycin in the presence or absence of chloride were
Figure 3: Overexpression of prestin in CHO cells enhances kanamycin-induced apoptosis. pcDNA3.1(-)-prestin or control vector were
transfected into CHO cells with lipofectamine as described in Materials and Methods and the cells were treated with 100 mM kanamycin for the time
indicated. (A): immunofluorescence staining of prestin in CHO cells showing .90% of the cells expressing prestin. (B): Control and prestin transfected
cells were treated with 100 mM kanamycin for 2 h, and analyzed by MTS assay as described in Materials and Methods. Y axis indicates the percentage
of viable cells relative to untreated cells. *, p,0.05. (C): Quantification of TUNEL positive cells in control and prestin-transfected cells treated with
100 mM kanamycin for 2 h or 4 h. ***, p,0.01.
doi:10.1371/journal.pone.0017322.g003
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shown in Figure 5B, kanamycin significantly upregulated Bcl-2
expression in prestin- expressing CHO cells, the effect of which
was completely abrogated in chloride-free solution. In contrast,
there was no significant difference of Bcl-2 expression in control
CHO cells.
Discussion
The results presented here have demonstrated, for the first time,
that prestin is able to act as a mediator of antibiotic-induced
apoptosis, the effect of which is probably coupled to its anion-
transporting capacity. While prestin has been identified as the
membrane-based motor protein specific to cochlear outer hair
cells and thought to be mainly responsible for active mechanical
amplification in mammalian ears [16,27,28], a recent study
revealed its ion-transporting capacity, which is independent of its
voltage-sensing capacity[17]. However, the physiological signifi-
cance of this ion transporting function has not been investigated.
In the current study, it is clearly shown that the kanamycin-
induced apoptosis in CHOs is greatly enhanced by prestin and
that the prestin-enhanced effect on apoptosis depends on
extracellular chloride. This suggests that chloride influx, which
has been reported to be involved in regulating cellular apoptotic
activities, may be involved in mediating the apoptosis-enhancing
effect of prestin. This could be due to the voltage-sensing capacity
of prestin that could sense the influx of cations through ionophore
kanamycin, and result in conformational change that facilitates
chloride transport. Alternatively, the exogenous expression of
prestin may activate endogenous chloride uptake pathway(s) upon
kanamycin treatment. However, this possibility and detailed
mechanism remain to be investigated. Nevertheless, the results
Figure 4: Prestin-expressing CHO cells exhibit anion transporting capacity. Control or prestin transfected cells were cultured on cover
slides for 24 h, and incubated with Krebs-Henseleit (KH) medium. (A): Measurement of membrane potential by voltage- fluorescent dye DiBAC4(3).
Arrows indicate the time when 100 mM kanamycin was added in the KH media. (a), Control cells; (b), prestin-transfected cells; (c), Quantitative analysis
of increasing rate of membrane potential; (d), Quantitative analysis of change of membrane potential compared to the base line. (B): Intracellular
chloride concentration was measured by MQAE dye in control or prestin transfected cells incubated in KH media. ***, p,0.01. (C): Intracellular
chloride concentration was measured in KH media depleted of chloride. NS, no significant difference.
doi:10.1371/journal.pone.0017322.g004
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motility in the mammalian cochlear, prestin is very likely to play
an important role, either directly or indirectly, in transuding
apoptotic signals in response to extracellular stimuli, such as
antibiotics.
A growing number of evidence suggests that anions, particularly
chloride, play an important role during the cell death process.
Early studies on ions and apoptosis showed the activation of an
outwardly rectifying chloride current (ORCC) upon CD95
receptor stimulation in Jurkat T-cells [29]. Additionally, a
swelling-induced chloride current, which could be inhibited with
NPPB or lanthanum, was observed in Xenopus oocytes upon
treatment with pro-apoptotic sphingolipids, suggesting potential
involvement of the movement of chloride in the process of
apoptosis. Recently, more Cl
- channels have been implicated in
the regulation of apoptosis in a variety of cell types (1–3)]. Among
the proposed mechanisms accounting for the proapoptotic effect of
anion channels, cellular acidification due to anion influx has been
demonstrated to trigger mitochondria apoptotic cascade involving
Bcl-2. In the present study, kanamycin is demonstrated to induce
an influx of chloride and apoptosis in cells transfected with prestin.
This response can be completely abrogated when chloride was
removed from the extracellular media, indicating that the prestin-
mediated apoptosis depends on chloride influx. Moreover, that
prestin-mediated apoptosis is associated with an increase in
antiapoptotic protein bcl-2, implying possible activation of
intrinsic mitochondria cascade subsequent to prestin-mediated
chloride influx.
The presently demonstrated apoptosis-enhancing effect of
prestin, together with its well-established OHC-specific expression,
may explain the observation that outer hair cells are more
vulnerable to antibiotic administration compared with other cells
in the cochlear. An important question that logically follows would
be why prestin, the crucial protein responsible for amplification of
sounds, is involved in the process of apoptosis in OHCs, the
consequence of which will result in permanent hearing damage.
What is the physiological significance of this seemingly paradoxical
role of prestinin OHCs? Of particular interest, inour mouse model,
we noticed, upon kanamycin treatment, a time-dependent down-
regulation of prestin transcript prior to detectable apoptotic cell
death observed in OHCs which becomes obvious on day 14.
Considering its crucial role in mechanical amplification of sounds,
one might expect that the reduced expression of prestin could lead
to compromised hearing ability. Indeed, subsequent to a significant
downregulation of prestin mRNA and disordered distribution of its
protein observed on day 7, the onset of auditory threshold shift
appeared around day 10, which was also prior to detectable
apoptosis and deformationof the cochlea wasobserved after day 14.
Subsequently, long term exposure to kanamycin also induced
apoptosis in other cochlear cells including spiral ganglion cells and
stria vascularis cells, which is expected to result in permanent and
irreversible hearing loss, as indicated by a significant shift in
auditory thresholds in almost all frequencies tested in our animal
model. Thus, the observed down-regulation of prestin during early
exposure to kanamycin appears to serve two critically important
purposes, to prevent or reduce apoptosis in OHCs and to inform of
hazardous environment with compromised hearing sensitivity
before severe or permanent hearing damage may occur. The time
window between prestin downregulation and ultimate cell damage
raises the possibility to reverse aminoglycoside-induced ototoxicity
at this stage in clinical practice. In fact, the transient hearing lose in
patients induced by aminoglycosides can be reversed after
withdrawal of drug treatment at early stage of ototoxicity[30].
Although it remains to be elucidated how prestin expression may be
suppressed by kanamycin, it is clear that such suppressive effect
could be oneof the oto-protectivemechanisms ofOHCs inresponse
to the hostile exposure.
In closing, our study has demonstrated a previously undefined
role of prestin in regulating apoptosis in OHCs. Downregulation
Figure 5: Prestin-enhanced kanamycin-induced apoptosis
depends on extracellular chloride. Control or prestin-transfected
CHO cells were exposed to 100 mM kanamycin for 2 h in the presence
or absence of extracellular chloride in KH media. Normal culture media
F-12K was used as a control. (A): TUNEL staining showed when cells
were incubated in chloride-free KH solution, the kanamycin-induced
effect in prestin-expressing CHO cells was abolished. *,p,0.05. (B):
Western blot analysis of bcl-2 expression in control and prestin-
transfected cells upon 100 mM kanamycin treatment in KH media with
or without chloride for 2 h. *,p,0.05. Images are representative of 3
separate experiments.
doi:10.1371/journal.pone.0017322.g005
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sound amplification and its newly defined role in apoptosis, may
serve as an important and sensitive protective mechanism against
ototoxic substances. The present findings also shed new light to
our understanding of the cellular process and mechanism
underlying the early stage of antibiotic-induced ototoxicity. It
remains to be elucidated whether prestin is involved in the final
stage of antibiotics-induced cell death or other cell death
mechanisms may also be involved leading to the final and
permanent damage of OHCs.
Materials and Methods
Animal model of ototoxicity
Young adult male BALB/c mice (4 weeks old) were used for
animal model of kanamycin induced ototoxicity. Mice were
approved by the University Committee on Use and Care of
Animals at the Chinese University of Hong Kong. In vivo studies
were performed with the approval of the Animal Experimentation
Ethics Committee of The Chinese University of Hong Kong. For
ototoxic deafening, mice were divided into saline control and
kanamycin treatment groups. Ten mice per group (ka-3d, ka-7d,
ka-10d, ka-14d, ka-21d) were subcutaneously injected kanamycin
sulfate (Ameresco, 0408-100G, USA, 750 mg/kg) twice daily for
the time indicated. The development of ototoxicity was evaluated
using auditory brainstem response (ABR) [18]. The animals were
sacrificed 5 days after termination of the treatment and the
cochleae were removed for immunocytochemistry or the extrac-
tion of total cochlear RNA.
Cell Culture and transfection
CHO-K1 (ATCC, CCL-61) cells were maintained in F-12k
culture medium (Kaighn’s Modification of Ham’s F-12 Medium,
ATCC, 30-2004) with 10% Fetal Bovine Serum (Gibco, 10270-
106) at 37uC in 95% O2/5% CO2. For transfection, CHO-K1
cells cultured in 60 mm dish for 24 h were transfected with 5 ug of
pcDNA3.1(-)-Prestin or control vector (Provided by Prof. Jing
Zheng at Auditory Physiology Laboratory, Department of
Communication Sciences and Disorders, Northwestern Universi-
ty) in 10 ml of Lipofectamine (Invitrogen, 18324–020). 48 hours
after transfection, cells were diluted and selected with fresh media
containing 1 mg/ml G418 (neomycin) for one week, and survived
cells were pooled and propagated for further analysis. For
kanamycin treatment, control or prestin transfected cells were
washed with PBS and incubated with 100 mM kanamycin for time
indicated.
Tissue preparation and Immunostaining
For immunohistochemistry, the mice treated with kanamycin
were anaesthetized with CO2, and the cochlea were subsequently
dissected and perfused with 4% paraformaldehyde in PBS for a
while, and fixed in the same fixation fluid for overnight at 4uC.
The specimens were then washed with PBS and decalcified with
4% EDTA in PBS (pH 7.4) for 3–5 days at 4uC. Decalcified
cochlea specimens were then embedded in paraffin, cut into
sections (5 mm), and placed on coated slides. For immunohisto-
chemistry, sections were stained for overnight at 4uC with prestin
polyclonal rabbit antibody (1:70 diluted, Santa Cruz, sc30163,
USA) using the microwave antigen retrieval technique. After
washing, sections were stained with the secondary antibodies with
peroxidase-conjugated anti-rabbit followed by rabbit peroxidase
anti-peroxidase (Dako Corporation, CA) for 1 hour at room
temperature. After being washed, color was developed with 3, 3-
diaminobenzidine and counterstained with hematoxylin. An
isotype-matched IgG was used as a negative control throughout
the study.
For immunofluorescence, the specimens were rinsed with PBS
and the bone surrounding the organ of Corti removed.
Subsequently, the tissues were fixed in 4% paraformaldehyde for
1 h at room temperature, followed by permeabilization with 0.3%
Triton X-100 for 1.5 h. After a rinsing in PBS, the tissues were
incubated for 2 h in blocking solution containing 2% bovine
serum albumin and 5% normal goat serum in PBS. Tissues were
rinsed in PBS and incubated with prestin polyclonal rabbit
antibody (1:70, Santa Cruz, sc30163, USA) or FITC-conjugated
Phalloidin (1:100 sigma, p5282, USA). Tissues were rinsed in PBS
for 10 min, and incubated for 30 min with a secondary antibody
(1:200 diluted, goat anti-rabbit antibody conjugated Rhodamine,
Santa Cruz, sc2091, USA). After a 10 min PBS rinse, the basilar
membrane was separated and mounted on the slides in anti-fading
mounting medium and photographed with the laser confocal
microscope (Zeiss).
Isolation of cochlear total RNA and RT-PCR (Q-PCR)
Total RNA was isolated from mice cochlea by using TRIzol
reagent (Invitrogen) following the protocol provided by the
manufacturer. Total RNA (5 mg) was reverse transcribed using
M-MLV Reverse Transcriptase (USB, GE Healthcare) in a 20-ml
reaction and 2 ml of reverse-transcription product was amplified by
PCR using standard protocols. Prestin TaqMan primer and probes
were obtained from Applied Biosystems (Mm01167265_m1). A 96-
well plate wasused for the PCRreactions. Assayswereperformed in
triplicate on an Applied Biosystems 7500Fast Real-Time PCR
System and average Ct values normalized relative to expression of
mouse-slc26a5.
MTS assay
Control or prestin transfected cells were plated in triplicate wells
at a density of 5610
3cells/well in 96 flat-bottomed plates, allowed
to attach overnight, and then 100 mM kanamycin added for 2 h.
Cell viability following drug treatment was assessed using the
CellTiter-GIo Luminescent Cell Viability Assay (Promega,
Madison, MI).
Western Blot
Whole cell lysates were analyzed by western blot using standard
procedures. Primary antibodis used were: anti-bcl-2 (1:500) (Santa
Cruz Biotech), anti-tubulin (1:1000) (Santa Cruz Biotech).
Membrane potential measurement by voltage-sensitive
fluorescent dye
The measurement of membrane potential changes by Di-
BAC4(3) [Bis-(1,3-dibutylbarbituric acid)-trimethine oxonol] dye
was performed with excitation maxima at approximately 490 nm.
Briefly, cells were cultured on cover slides for 24 h, and incubated
with Krebs-Henseleit (KH) medium adjust to 290mOsm with
Glucose, balanced pH with 95% O2,5 %C O 2 mixed gas)
contained 1 mM/ml DiBAC4(3) for 20 min at room temperature
in darkness. Experiments were carried out in the constant presence
of DiBAC4(3) dye. The fluorescence emission was collected at
535 nm. Depolarization results in a increasing in fluorescence
intensity, whereas hypo-polarization causes decreasing fluores-
cence intensity in cells [31].
Intracellular chloride measurement by MQAE dye
Cells were cultured on round cover slides for 24 h. Before
measurement, cells were incubated in 2 ml KH solution contained
Prestin Mediated Apoptosis in Ototoxicity
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30 min at 37uC in darkness. Cells were then incubated in fresh
KH solution without MQAE dye, the intracellular fluorescence
intensities were measured at 460 nm.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling
DNA fragmentation was detected by the TUNEL technique,
which detects DNA fragmentation during apoptosis. For tissues,
the specimens were prepared as described above. For CHO-K1
cells, cells transfected with prestin or pcDNA3.1(-) were cultured
on cover slides for 24 h and treated with 100 mM kanamycin for
2–4 h. Cells were then fixed with methanol and acetone (1:1
mixed) for 15 min at 4uC, washed with PBS, and permeabilized
with 0.3% Triton X-100 for 20 min. Tissues or cells were then
incubated with the TUNEL assay reaction mixture (mixed enzyme
solution with label solution at dilution 1:9, In Situ Cell Death
Detection Kit, Roche) at 37uC, in darkness for 60 min, followed
by counterstained with Propidium Iodide (PI) or Hoechest 33342
for 10 min. After thoroughly washing with PBS, the samples were
mounted in anti-fading mounting medium.
Statistical Analysis
The data were processed using Prism 3.0 software. Values are
reported as means 6 S.D. if not indicated otherwise. Comparisons
among values for all groups were performed by one-way ANOVA
or student t test. A ‘‘P’’ value of less than 0.05 was considered
statistically significant.
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